In two different blood-brain barrier cell models exposed to HIV, CB2 receptor activation had opposite effects: improving barrier integrity in cells with high CB2 expression but showing no benefit or worsening damage in cells with low CB2 levels.
People living with HIV who use cannabis, and researchers studying cannabinoid effects on the blood-brain barrier.
50-fold difference in CB2 receptor response between the two cell lines determined opposite outcomes
What the researchers found
Both endothelial cell lines responded similarly to HIV-conditioned media (increased permeability, decreased tight junction proteins). However, CB2 receptor activation improved all barrier measures in hCMEC/D3 cells (high CB2 expression, 50-fold higher cAMP response) while showing no benefit or aggravation in HBMEC/ci18 cells (low CB2 expression).
Why it matters
Cannabis use is common among people living with HIV, and blood-brain barrier disruption contributes to HIV-associated neurocognitive disorders. This study shows that whether cannabinoids help or harm the barrier may depend on individual differences in CB2 receptor expression, potentially explaining conflicting findings in previous research.
The numbers in context
hCMEC/D3 cells showed over 50-fold higher cAMP response to CB2 activation compared to HBMEC/ci18 cells, correlating with higher CB2 receptor availability. Both cell lines showed similar HIV-induced barrier damage (increased dextran permeability, decreased tight junction proteins).
How the study worked
Researchers used two human brain endothelial cell lines (hCMEC/D3 and HBMEC/ci18) in multicellular blood-brain barrier models. Cells were exposed to conditioned media from HIV latently infected promonocytes and treated with cannabinoid receptor agonists. Barrier integrity was assessed via dextran permeability, tight junction proteins, cell viability, proliferation, and GPCR-mediated cAMP production.
What this study cannot tell us
In vitro cell line models do not fully replicate the complexity of the human blood-brain barrier. Only two cell lines were compared. HIV exposure was via conditioned media rather than direct infection. Individual variation in CB2 expression in living humans is not well characterized.
How to read the evidence
In vitro study comparing two cell lines with mechanistic analysis, but limited by the artificial nature of cell culture models.
When this study was published
Published in 2025 (preprint).
The bigger picture
This finding has important implications: if CB2 receptor density varies between individuals, cannabis could protect the blood-brain barrier in some people living with HIV while worsening it in others. This context-dependent effect aligns with previous clinical observations of variable cannabis outcomes in HIV populations.
Questions still open
- Do CB2 receptor levels vary significantly among people living with HIV? Could CB2 receptor expression be used as a biomarker to predict who might benefit from cannabinoid therapy? What genetic or epigenetic factors determine CB2 expression on brain endothelial cells?
Common questions
Does cannabis protect or damage the blood-brain barrier in HIV?
What is the blood-brain barrier?
Read the original research
Contrasting cannabinoid receptor 2 (CB2R)-mediated responses in two different models of Blood Brain Barrier in the context of HIV.
Research square
Citation
Delorme-Walker, Violaine; Au, Kaylin; Lim, Wei Ling; Sasaki, Takayo; Furihata, Tomomi; Lima, Daniel Siqueira; Iudicello, Jennifer; Milner, Richard; Marcondes, Maria Cecilia Garibaldi. (2025). Contrasting cannabinoid receptor 2 (CB2R)-mediated responses in two different models of Blood Brain Barrier in the context of HIV.. Research square. https://doi.org/10.21203/rs.3.rs-8310572/v1
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)